SHIRE PLC: Third quarter 2013 results date notification

Third quarter 2013 results date notification - October 24, 2013 
Dublin, Ireland - October 10, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG), will
announce third quarter 2013 earnings on Thursday October 24, 2013. 
Results press release will be   12:00 BST / 07:00 EDT                          
issued at:                                                                      
                                                                           
Investor conference call time:  14:00 BST / 09:00 EDT                           
Live conference call for investors: 
Flemming Ornskov, MD, Chief Executive Officer and Graham Hetherington, Chief
Financial Officer will host the investor and analyst conference call at 14:00
BST/9:00 EDT. 
The details of the conference call are as follows: 
UK dial in:                  08082370030 or 02031394830                         
                                                                           
US dial in:                  1 866 928 7517 or 1 718 873 9077                   
                                                                           
International Access         
http://wpc.1726.planetstream.net/001726/FEL_Events_International_Access_List.pdf 
     
Numbers:                                
                                                                           
Password/Conf ID:            71566006#                                          
                                                                           
Live Webcast:                http://www.shire.com/shireplc/en/investors         
Replay: 
A replay of the presentation will be available for two weeks by phone and by
webcast for three months. Details can be found on our Investor Relations
website http://www.shire.com/shireplc/en/investors. 
For further information please contact: 
Investor Relations  Souheil Salah (ssalah@shire.com)         +44 1256 894 160   
NOTES TO EDITORS 
Shire enables people with life-altering conditions to lead better lives. 
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs. 
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas. 
www.shire.com 
                                                                         
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX 
Press Release                                      
                                              
www.shire.com                                      
END 
-0- Oct/10/2013 06:00 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.